Clinical Trial Update: Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis [Phase 2]

View source ↗

Summary

Reports Phase 2 trial results on the efficacy and safety of Tamibarotene (AM80) for lupus nephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Tamibarotene (AM80) (tamibarotene)

Snippet

Sponsor: Kinki University | Conditions: Lupus Nephritis | Phase 2 | Status: UNKNOWN